| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0165-1781(79)90023-4 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0165178179900234?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:0165178179900234?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 233154 |
| P2093 | author name string | W. C. Duncan | |
| J. C. Gillin | |||
| N. Sitaram | |||
| P2860 | cites work | Successful Separation of Depressed, Normal, and Insomniac Subjects by EEG Sleep Data | Q33919542 |
| The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis | Q37177920 | ||
| Cholinergic mechanisms involved in cortical activation during arousal | Q39317498 | ||
| The Neuropharmacology of Sleep and Wakefulness | Q39722900 | ||
| Electroencephalographic Sleep Diagnosis of Primary Depression | Q40012827 | ||
| The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep | Q40056681 | ||
| Alterations in Motor Activity, Sleep, and Biochemistry in a Cycling Manic-Depressive Patient | Q40062883 | ||
| Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonist | Q40161625 | ||
| Scopolamine-induced muscarinic supersensitivity in normal man: Changes in sleep | Q40298479 | ||
| A cholinergic-adrenergic hypothesis of mania and depression | Q41509436 | ||
| A pharmacological model of paradoxical sleep: The role of cholinergic and monoamine systems | Q48934255 | ||
| The sleep of patients with manic-depressive psychosis, depressive type; an electroencephalographic study. | Q51371355 | ||
| Sleep disturbance in depressive syndromes | Q72821838 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sleep disturbance | Q102187069 |
| P304 | page(s) | 17-22 | |
| P577 | publication date | 1979-07-01 | |
| P1433 | published in | Psychiatry Research | Q15750888 |
| P1476 | title | Muscarinic supersensitivity: a possible model for the sleep disturbance of primary depression? | |
| Muscarinic supersensitivity: A possible model for the sleep disturbance of primary depression? | |||
| P478 | volume | 1 |
| Q38016668 | Acetylcholine and acetylcholine receptor subtypes in REM sleep generation. |
| Q26822244 | Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review |
| Q35648180 | Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial |
| Q40093757 | Antidepressant withdrawal-induced activation (hypomania and mania): Mechanism and theoretical significance |
| Q43729249 | Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women |
| Q34513911 | Biochemical pharmacology of paradoxical sleep |
| Q40095798 | Biochemistry and Regulation of Signal Transduction by Neuronal Acetylcholine Receptors |
| Q36848923 | Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression |
| Q33748982 | Changes in forebrain function from waking to REM sleep in depression: preliminary analyses of [18F]FDG PET studies |
| Q41348710 | Cholinergic mechanisms in affective disorders. Future directions for investigation |
| Q41240193 | Circadian rhythms and the pharmacology of affective illness |
| Q24634619 | Control of sleep and wakefulness |
| Q37585112 | Drug effects on REM sleep and on endogenous depression |
| Q46250279 | Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and mood |
| Q33955584 | Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder. |
| Q40134047 | Motion sickness: A modulatory role for the central cholinergic nervous system |
| Q48408672 | Muscarinic receptor density in skin fibroblasts and autopsied brain tissue in affective disorder |
| Q48642001 | Rapid Eye Movement (REM) sleep: cholinergic mechanisms |
| Q40298479 | Scopolamine-induced muscarinic supersensitivity in normal man: Changes in sleep |
| Q35752917 | Sleep disturbance and nonmalignant chronic pain: a comprehensive review of the literature |
| Q46811028 | Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls |
| Q91738516 | The Effect Of Fluvoxamine On Sleep Architecture Of Depressed Patients With Insomnia: An 8-Week, Open-Label, Baseline-Controlled Study |
| Q36469220 | The anterior cingulate cortex may enhance inhibition of lateral prefrontal cortex via m2 cholinergic receptors at dual synaptic sites. |
| Q43939708 | The effects of an orally administered cholinergic agonist on REM sleep in major depression |
| Q84110084 | [Psychopathological aspects of "raptus melancholicus"] |
Search more.